David A Gerber
Overview
Explore the profile of David A Gerber including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
83
Citations
805
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Motter J, Jackson K, Long J, Waldram M, Orandi B, Montgomery R, et al.
Am J Transplant
. 2020 Dec;
21(4):1612-1621.
PMID: 33370502
Incompatible living donor kidney transplant recipients (ILDKTr) have pre-existing donor-specific antibody (DSA) that, despite desensitization, may persist or reappear with resulting consequences, including delayed graft function (DGF) and acute rejection...
22.
23.
Pei X, Shao W, Xing A, Askew C, Chen X, Cui C, et al.
Mol Ther Methods Clin Dev
. 2020 Jul;
18:259-268.
PMID: 32637455
Adeno-associated virus (AAV) vectors have been successfully used in patients with bleeding disorders and blindness. For human liver targeting, two major factors restrict effective AAV transduction after systemic administration of...
24.
25.
Fesmire C, Petrella R, Fogle C, Gerber D, Xing L, Sano M
Ann Biomed Eng
. 2020 May;
48(8):2233-2246.
PMID: 32409902
Electroporation is a bioelectric phenomenon used to deliver target molecules into cells in vitro and irreversible electroporation (IRE) is an emerging cancer therapy used to treat inoperable tumors in situ....
26.
Jackson K, Long J, Motter J, Bowring M, Chen J, Waldram M, et al.
Transplantation
. 2020 Apr;
105(2):436-442.
PMID: 32235255
Background: Desensitization protocols for HLA-incompatible living donor kidney transplantation (ILDKT) vary across centers. The impact of these, as well as other practice variations, on ILDKT outcomes remains unknown. Methods: We...
27.
Baldwin X, Desai C, Gerber D
J Gastrointest Surg
. 2020 Feb;
24(7):1709-1711.
PMID: 32016673
No abstract available.
28.
Desai C, Gerber D
World J Hepatol
. 2020 Jan;
12(1):6-9.
PMID: 31984116
With the advances and clinical growth in liver transplantation over the last four decades the focus on expanding deceased donor organs has been in need of scientific research. In the...
29.
Cools K, Moon A, Burke L, McGinty K, Strassle P, Gerber D
Liver Transpl
. 2019 Nov;
26(2):203-214.
PMID: 31677319
Single hepatocellular carcinoma (HCC) tumors can be successfully eradicated with thermal ablation (TA). We assessed the validity of the Liver Imaging Reporting and Data System Treatment Response (LR-TR) criteria with...
30.
Shao W, Pei X, Cui C, Askew C, Dobbins A, Chen X, et al.
Gene Ther
. 2019 Oct;
26(12):504-514.
PMID: 31570819
Although therapeutic outcomes have been achieved in hemophilia patients after delivery of clotting factor genes to the liver using adeno-associated virus (AAV) vectors, it is well known that the preclinical...